Modifying the blood–brain barrier by targeting claudin‐5: Safety and risks-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Modifying the blood–brain barrier by targeting claudin‐5: Safety and risks

Published:2022-05-04 Issue:1 Volume:1514 Page:62-69
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Annals of the New York Academy of Sciences

Author:

Wakayama Erika¹,Kuzu Taiki²³,Tachibana Keisuke³,Hirayama Ryuichi⁴,Okada Yoshiaki³,Kondoh Masuo³

Affiliation:

1. Faculty of Pharmaceutical Sciences Osaka University Osaka Japan

2. College of Pharmaceutical Sciences Ritsumeikan University Kusatsu Japan

3. Graduate School of Pharmaceutical Sciences Osaka University Osaka Japan

4. Graduate School of Medicine Osaka University Osaka Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nyas.14787

Reference58 articles.

1. THE CELL BIOLOGY OF THE BLOOD-BRAIN BARRIER

2. Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches

3. Structure and function of the blood–brain barrier

4. Brain endothelial cells and the glio-vascular complex

5. Multifunctional strands in tight junctions

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-625-5p is a potential therapeutic target in sepsis by regulating CXCL16/CXCR6 axis and endothelial barrier;International Immunopharmacology;2024-08

2. Mosaic deletion of claudin-5 reveals rapid non-cell-autonomous consequences of blood-brain barrier leakage;Cell Reports;2024-03

3. Radiotherapy opens the blood–brain barrier and synergizes with anlotinib in treating glioblastoma;Radiotherapy and Oncology;2023-06

4. Clinical gene therapy development for the central nervous system: Candidates and challenges for AAVs;Journal of Controlled Release;2023-05

5. A year in review: brain barriers and brain fluids research in 2022;Fluids and Barriers of the CNS;2023-04-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3